| Id |
Description |
Lang |
Type |
Status |
Case? |
Module |
| 2116391000168113 |
Hexaxim (Bordetella pertussis filamentous haemagglutinin antigen 25 microgram + Bordetella pertussis toxoid 25 microgram + diphtheria toxoid 20 international units + Haemophilus influenzae serotype b conjugate (polyribosylribitol phosphate to tetanus toxoid) antigen 12 microgram + hepatitis B surface antigen 10 microgram + poliovirus serotype 1 inactivated antigen 40 D antigen units + poliovirus serotype 2 inactivated antigen 8 D antigen units + poliovirus serotype 3 inactivated antigen 32 D antigen units + tetanus toxoid 40 international units) injection suspension, 0.5 mL syringe (trade product unit of use) |
en |
Fully specified name |
Inactive |
Case sensitive |
Australian Medicines Terminology module |
| 2116401000168110 |
Hexaxim injection suspension, 0.5 mL syringe |
en |
Synonym |
Inactive |
Case sensitive |
Australian Medicines Terminology module |
| 3111231000168118 |
Hexaxim (Bordetella pertussis filamentous haemagglutinin antigen 25 microgram + Bordetella pertussis toxoid 25 microgram + diphtheria toxoid 20 international units + Haemophilus influenzae serotype b conjugate (polyribosylribitol phosphate to tetanus toxoid) antigen 12 microgram + hepatitis B surface antigen 10 microgram + poliovirus serotype 1 inactivated antigen 40 D antigen units + poliovirus serotype 2 inactivated antigen 8 D antigen units + poliovirus serotype 3 inactivated antigen 32 D antigen units + tetanus toxoid 40 international units) injection, 0.5 mL syringe (trade product unit of use) |
en |
Fully specified name |
Active |
Case sensitive |
Australian Medicines Terminology module |
| 3111241000168110 |
Hexaxim injection, 0.5 mL syringe |
en |
Synonym |
Active |
Case sensitive |
Australian Medicines Terminology module |
| Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
| Hexaxim injection, 0.5 mL syringe |
has manufactured dose form |
injection |
true |
Inferred relationship |
Some |
|
|
| Hexaxim injection, 0.5 mL syringe |
Is a |
Hexaxim |
true |
Inferred relationship |
Some |
|
|
| Hexaxim injection, 0.5 mL syringe |
Is a |
diphtheria + tetanus + pertussis + hepatitis B + polio trivalent + Haemophilus influenzae type b conjugate (PRP-T) vaccine injection, 0.5 mL syringe |
true |
Inferred relationship |
Some |
|
|
| Hexaxim injection, 0.5 mL syringe |
Is a |
trade product unit of use |
true |
Inferred relationship |
Some |
|
|
| Hexaxim injection, 0.5 mL syringe |
has manufactured dose form |
injection suspension |
false |
Inferred relationship |
Some |
|
|
| Hexaxim injection, 0.5 mL syringe |
has unit of use |
syringe |
true |
Inferred relationship |
Some |
2019578073 |
|
| Hexaxim injection, 0.5 mL syringe |
has intended active ingredient |
tetanus toxoid |
true |
Inferred relationship |
Some |
1065467354 |
|
| Hexaxim injection, 0.5 mL syringe |
has Australian BoSS |
tetanus toxoid |
true |
Inferred relationship |
Some |
1065467354 |
|
| Hexaxim injection, 0.5 mL syringe |
has Australian BoSS |
poliovirus type 3 inactivated antigen |
true |
Inferred relationship |
Some |
858587816 |
|
| Hexaxim injection, 0.5 mL syringe |
has intended active ingredient |
poliovirus type 3 inactivated antigen |
true |
Inferred relationship |
Some |
858587816 |
|
| Hexaxim injection, 0.5 mL syringe |
has intended active ingredient |
poliovirus type 1 inactivated antigen |
true |
Inferred relationship |
Some |
1398940072 |
|
| Hexaxim injection, 0.5 mL syringe |
has Australian BoSS |
poliovirus type 1 inactivated antigen |
true |
Inferred relationship |
Some |
1398940072 |
|
| Hexaxim injection, 0.5 mL syringe |
has Australian BoSS |
Bordetella pertussis filamentous haemagglutinin antigen |
true |
Inferred relationship |
Some |
2019578072 |
|
| Hexaxim injection, 0.5 mL syringe |
has intended active ingredient |
Bordetella pertussis filamentous haemagglutinin antigen |
true |
Inferred relationship |
Some |
2019578072 |
|
| Hexaxim injection, 0.5 mL syringe |
has Australian BoSS |
Haemophilus influenzae type b conjugate (PRP-T) antigen |
true |
Inferred relationship |
Some |
1053482664 |
|
| Hexaxim injection, 0.5 mL syringe |
has intended active ingredient |
Haemophilus influenzae type b conjugate (PRP-T) antigen |
true |
Inferred relationship |
Some |
1053482664 |
|
| Hexaxim injection, 0.5 mL syringe |
has Australian BoSS |
diphtheria toxoid |
true |
Inferred relationship |
Some |
404338930 |
|
| Hexaxim injection, 0.5 mL syringe |
has intended active ingredient |
diphtheria toxoid |
true |
Inferred relationship |
Some |
404338930 |
|
| Hexaxim injection, 0.5 mL syringe |
has Australian BoSS |
poliovirus type 2 inactivated antigen |
true |
Inferred relationship |
Some |
424521064 |
|
| Hexaxim injection, 0.5 mL syringe |
has intended active ingredient |
poliovirus type 2 inactivated antigen |
true |
Inferred relationship |
Some |
424521064 |
|
| Hexaxim injection, 0.5 mL syringe |
has intended active ingredient |
Bordetella pertussis toxoid |
true |
Inferred relationship |
Some |
157541576 |
|
| Hexaxim injection, 0.5 mL syringe |
has Australian BoSS |
Bordetella pertussis toxoid |
true |
Inferred relationship |
Some |
157541576 |
|
| Hexaxim injection, 0.5 mL syringe |
has Australian BoSS |
hepatitis B surface antigen |
true |
Inferred relationship |
Some |
1789233688 |
|
| Hexaxim injection, 0.5 mL syringe |
has intended active ingredient |
hepatitis B surface antigen |
true |
Inferred relationship |
Some |
1789233688 |
|